Gang J. Jin

168 Changhai Road
Yangpu, 200433, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 233 publications

Recent Advances in Vision-Based Beef Cattle Body Measurement Technologies.

Recent Advances in Vision-Based Beef Cattle Body Measurement Technologies.

Journal: Animals : an open access journal from MDPI

Published: June 08, 2026

Development and Validation of Nomograms for Predicting Overall Survival and Recurrence After Upfront Pancreatic Resection for Ductal Adenocarcinoma: A Single-Institution Analysis of 2958 Patients.

Development and Validation of Nomograms for Predicting Overall Survival and Recurrence After Upfront Pancreatic Resection for Ductal Adenocarcinoma: A Single-Institution Analysis of 2958 Patients.

Journal: Annals of surgical oncology

Published: May 21, 2026

Rewiring metabolic-immune circuitry in pancreatic ductal adenocarcinoma (PDAC).

Rewiring metabolic-immune circuitry in pancreatic ductal adenocarcinoma (PDAC).

Journal: Cancer pathogenesis and therapy

Published: April 22, 2026

Discovery and validation of a prognostic SPP1/PLAU signature in HPV-negative oropharyngeal squamous cell carcinoma.

Discovery and validation of a prognostic SPP1/PLAU signature in HPV-negative oropharyngeal squamous cell carcinoma.

Journal: BMC medical genomics

Published: March 18, 2026

Rosmarinic acid ameliorates radiation-induced intestinal injury through PI3K/AKT/NF-κB/MMP9 axis inhibition: From network pharmacology prediction to experimental validation.

Rosmarinic acid ameliorates radiation-induced intestinal injury through PI3K/AKT/NF-κB/MMP9 axis inhibition: From network pharmacology prediction to experimental validation.

Journal: Tissue & cell

Published: March 13, 2026

Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post- neoadjuvant therapy" [Cancer Lett. (2026), Online ahead of print].

Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post- neoadjuvant therapy" [Cancer Lett. (2026), Online ahead of print].

Journal: Cancer letters

Published: February 06, 2026

Molecular mechanism of propofol in reducing kidney injury induced by autologous orthotopic liver transplantation.

Molecular mechanism of propofol in reducing kidney injury induced by autologous orthotopic liver transplantation.

Journal: Frontiers in immunology

Published: November 24, 2025

The triad of maternal gut-breast milk-infant gut microbial transmission in early life as a critical pathway for microbial inheritance.

The triad of maternal gut-breast milk-infant gut microbial transmission in early life as a critical pathway for microbial inheritance.

Journal: Gut microbes

Published: November 17, 2025

T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical trial.

T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical trial.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: October 30, 2025

A mitochondria-related gene-based signature predicts pancreatic ductal adenocarcinoma clinical outcome and revealed CAMK2A/THEM4 regulates progression phenotypes and mitophagy in vivo and in vitro.

A mitochondria-related gene-based signature predicts pancreatic ductal adenocarcinoma clinical outcome and revealed CAMK2A/THEM4 regulates progression phenotypes and mitophagy in vivo and in vitro.

Journal: Journal of translational medicine

Published: August 22, 2025

The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant therapy.

The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant therapy.

Journal: Cancer letters

Published: June 28, 2025

Jiedu Xiaozhen Granules for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Mediated Skin Toxicity: Protocol for a Randomized Controlled Trial.

Jiedu Xiaozhen Granules for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Mediated Skin Toxicity: Protocol for a Randomized Controlled Trial.

Journal: JMIR research protocols

Published: June 24, 2025

Showing 1-12 of 233

Last Updated: 09/26/2026